Japan's Taiho Looks At Partnerships To Jumpstart Gastric Cancer Drug Global Expansion
Tokyo-based Taiho Pharmaceutical Nov. 19 announced the European Medicines Agency accepted for review the company's marketing application for the gastric cancer drug S-1